respiratory
Medicines

Respiratory drug development not sophisticated enough


The current approach to drug discovery in respiratory medicine is not sophisticated enough to meet the needs of the industry and patients, an expert group says. At a European Respiratory Society summit set up to identify some of the barriers to drug discovery the group noted that drug development in respiratory medicine was way behind that ...

Already a member?

Enter your email to keep reading.


OR